Importantly, those that received Eritoran treatment after PR8 infection but prior to Sp3 superinfection showed a significant decrease (P < 0.05) in both COX2 and IFN-β mRNA expression and a nonsignificant trend toward decreased IL-1β and TNF-α mRNA expression (Fig. S2). This evidence concerns the gene SP3 and infection.